On October 5, 2021, the U.S. Department of Commerce, Bureau of
Industry and Security (BIS), published a final rule amending the
Export Administration Regulations (EAR) to include controls on
certain biotechnology-related software, and technology used to
develop that software, as emerging technology. Specifically, the
controls apply to software designed for nucleic acid assemblers and
synthesizers that are capable of designing and building functional
genetic elements from digital sequence data.
BIS, consistent with its obligations under the Export Control
Reform Act of 2018 (ECRA), previously identified this software as
potential emerging technology essential to U.S. national security
that could be misused for biological weapons purposes in a notice
of proposed rulemaking on November 6, 2020. The final rule comes on
the heels of the 42-country Australia Group's decision to add
the software to its biological equipment control list, thereby
aligning U.S. controls with